作者: Ger Stienen , Eyk Jennifer E Van , Der Velden Jolanda Van , Anne M Murphy , Pingbo Zhang
DOI:
关键词: Biomarker (medicine) 、 Cardiology 、 Internal medicine 、 Pharmacology 、 Heart failure 、 Medicine 、 Antibody 、 Cardiac troponin 、 Threonine 、 Serine 、 Phosphorylation 、 Tyrosine
摘要: This invention relates to novel phosphorylation sites in cardiac Troponin I that are associated with the onset of heart failure. The sites, i.e., serine 5, tyrosine 26, threonine 51, 166, 181 and/or 199, can be used as biomarkers for (i) identifying subjects at risk development failure, (ii) treating having a higher than normal level biomarker, and (iii) monitoring therapy subject Also described antibodies, reagents, kits carrying out method present invention.